Weight loss in patients with head and neck cancer during and after conventional and accelerated radiotherapy

Acta Oncologica

Volumn 52, Issue 4, 2013, Pages 711-718

  Ottosson, Sandra ^a   Zackrisson, Björn ^a   Kjellén, Elisabeth ^b   Nilsson, Per ^b   Laurell, Göran ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; ENTERIC FEEDING; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; TUMOR LOCALIZATION; WEIGHT REDUCTION; CANCER PATIENT; NUTRITIONAL STATUS; OBESITY; WEIGHT CHANGE;

ACCELERATION; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; SWEDEN; WEIGHT LOSS;

EID: 84875933645     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.731524     Document Type: Article

References (25)

1. Chasen MR, B hargava R. A descriptive review of the factors contributing to nutritional compromise in patients with head and neck cancer. Support Care Cancer 2009; 17: 1345-51.
2. van Bokhorst-de van der Schueren MA, van Leeuwen PA, Sauerwein HP, Kuik DJ, Snow GB, Quak JJ. Assessment of malnutrition parameters in head and neck cancer and their relation to postoperative complications. Head Neck 1997; 19: 419-25.
3. Ravasco P, M onteiro-Grillo I, V idal PM, Camilo ME. N utritional deterioration in cancer: The role of disease and diet. Clin Oncol (R Coll Radiol) 2003; 15: 443-50.
4. Kondrup J, A llison S P, E lia M, V ellas B, P lauth M. E SPEN guidelines for nutrition screening 2002. Clin Nutr 2003; 22: 415-21.
5. Silver H J, D ietrich M S, M urphy B A. C hanges in body mass, energy balance, physical function, and infLammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy. Head Neck 2007; 29: 893-900.
6. Vissink A, J ansma J, S pijkervet FKL, B urlage FR, C oppes RP. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 2003; 14: 199-212.
7. Beaver ME, M atheny KE, R oberts DB, M yers JN. P redictors of weight loss during radiation therapy. J Otolaryngol Head Neck Surg 2001; 125: 645-8.
8. Pauloski BR, R ademaker A W, L ogemann JA, S tein D, B eery Q, Nweman L et al. PretreatmenTswallowing function in patients with head and neck cancer. Head Neck 2000; 22: 474-82.
9. Mehanna H, W est CML, N utting C, Paleri V. Head and neck cancer-Part 2: Treatment and prognostic factors. BMJ Open 2010; 341: 721-5.
10. Zackrisson B, N ilsson P, K jell é n E, J ohansson K-A, M odig H, Brun E, et al. Two-year results from a Swedish study on conventional versuSaccelerated radiotherapy in head and neck squamous cell carcinoma-The ARTSCAN study. Radiother Oncol 2011; 100: 41-8.
11. Johansson K-A, N ilsson P, Z ackrisson B, O hlson B, K jell é n E, Mercke C, et al. The quality assurance process for the ARTSCAN head and neck study-a practical interactive approach for QA in 3DCRT and IMRT. Radiother Oncol 2008; 87: 290-9.
12. Vall é n C, H agell P, W estergren A. V alidity and userfriendliness of the minimal eating observation and nutrition form-version II (MEONF-II) for undernutrition risk screening. Food Nutr Res 2011; 55: DOI: 10.3402/fnr. v55i0.5801.
13. EORTC Late Effects Working Group. L ENTSOMA tables. Radiother Oncol 1995; 35: 17-60.
14. Mor V, Laliberte L, M orris JN, W iemann M. The Karnofsky Performance Status Scale: An examination of its reliabi lity and validity in a research setting. Cancer 1984; 53: 2002-7.
15. Jager-Wittenaar H, D ijkstra P U, V issink A, van der Laan B F, van Oort RP, Roodenburg JL. Critical weight loss in head and neck cancer-prevalence and risk factorSat diagnosis: An explorative study. Support Care Cancer 2007; 15: 1045-50.
16. Mangar S, S levin N, M ais K, S ykeSa. E valuating predictive factors for determining enteral nutrition in patients receiving radical radiotherapy for head and neck cancer: A retrospective review. Radiother Oncol 2006; 78: 152-8.
17. Ehrsson YT, Langius-Eklöf A, Laurell G. N utritional surveillance and weight loss in head and neck cancer patients. Support Care Cancer 2012; 20: 757-65.
18. Locher JL, B onner JA, Carroll WR, Caudell JJ, K eith JN, Kilgore ML, et al. Prophylactic percutaneous endoscopic gastrostomy tube placement in treatment of head and neck cancer. JPEN J ParenteRenteral Nutr 2011; 35: 365-74.
19. Ehrsson YT, Langius-Eklöf A, B ark T, Laurell G. P ercutaneous endoscopic gastrostomy (PEG)-a long-term follow-up study in head and neck cancer patients. Clin OtolaryngoLallied Sci 2004; 29: 740-6.
20. Langmore S, K risciunas GP, M iloro KV, E vans SR, C heng DM. Does PEG use cause dysphagia in head and neck cancer patients? Dysphagia 2012; 27: 251-9.
21. Zogbaum A T, F itz P, D uffy V. T ube feeding may improve adherence to radiation treatmenTschedule in head and neck cancer: An outcomes study. Top Clin Nutr 2004; 19: 95-106.
22. Senft M, F ietkau R, I ro H, Sailer D, Sauer R. The Influence of supportive nutritional therapy via percutaneous endoscopically guided gastrostomy on the quality of life of cancer patients. Support Care Cancer 1993; 1: 272-5.
23. SilandeRe, Nyman J, B ove M, J ohansson L, Larsson S, HammerliDe. Impact of prophylactic percutaneous endoscopic gastrostomy on malnutrition and quality of life in patients with head and neck cancer-a randomized study. Head Neck 2012; 34: 1-9.
24. Assenat E, Thezenas S, Flori N, P ere-Charlier N, G arrel R, Serre A, et al. Prophylactic percutaneous endoscopic gastrostomy in patients with advanced head and neck tumors treated by combined chemoradiotherapy. J Pain Symptom Manage 2011; 42: 548-56.
25. August D A, H uhmann M B. A SPEN clinical guidelines: Nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J ParenteRenteral Nutr 2009; 33: 472-500.